An experimental inhibitor regrew cartilage in aged mice, opening up an alternative to arthritis and prosthetics.
IRVINE, Calif.--(BUSINESS WIRE)--Immunis, Inc., a private biotech company developing an innovative treatment for age and disease-related immune decline, announces its first-in-human injection of IMM01 ...
Scientists have uncovered a direct molecular mechanism by which gut bacteria inject proteins into human cells, reshaping immune responses and potentially driving inflammatory disease. Scientists have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results